MLTX (MoonLake Immunotherapeutics) Short Ratio


MLTX MoonLake Immunotherapeutics MLTX
28 GF Score
Price $18.95
! 3 Warning Signs
View Full Analysis

What is MoonLake Immunotherapeutics Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MLTX
28GF Score
MoonLake Immunotherapeutics MLTX
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MoonLake Immunotherapeutics Business Description

Address Dorfstrasse 29, Zug, CHE, 6300
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
28GF Score

Get the complete analysis for MLTX

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.95
Price